Want to see MEDS full AI Analyst Report?
Total Valuation
DataMeds AI has a market cap or net worth of $9.87M. The enterprise value is $38.31.
Market Cap$9.87M
Enterprise Value$38.31
Share Statistics
DataMeds AI has 3,197,633 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,197,633
Owned by Insiders16.89%
Owned by Institutions―
Financial Efficiency
DataMeds AI’s return on equity (ROE) is 8.14 and return on invested capital (ROIC) is -659.05%.
Return on Equity (ROE)8.14
Return on Assets (ROA)-3.32
Return on Invested Capital (ROIC)-659.05%
Return on Capital Employed (ROCE)-119.52
Revenue Per Employee752.83K
Profits Per Employee-3.27M
Employee Count31
Asset Turnover0.77
Inventory Turnover20.11
Valuation Ratios
The current PE Ratio of DataMeds AI is ―. DataMeds AI’s PEG ratio is -0.00028.
PE Ratio―
PS Ratio1.22
PB Ratio-2.28
Price to Fair Value-2.28
Price to FCF-2.61
Price to Operating Cash Flow-0.69
PEG Ratio-0.00028
Income Statement
In the last 12 months, DataMeds AI had revenue of 23.34M and earned -101.27M in profits. Earnings per share was -71.50.
Revenue23.34M
Gross Profit-9.64M
Operating Income-81.19M
Pretax Income-101.27M
Net Income-101.27M
EBITDA-93.48M
Earnings Per Share (EPS)-71.50
Cash Flow
In the last 12 months, operating cash flow was -13.74M and capital expenditures 149.68K, giving a free cash flow of -13.59M billion.
Operating Cash Flow-13.74M
Free Cash Flow-13.59M
Free Cash Flow per Share-4.25
Dividends & Yields
DataMeds AI pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.04
52-Week Price Change-91.73%
50-Day Moving Average2.29
200-Day Moving Average8.28
Relative Strength Index (RSI)58.81
Average Volume (3m)9.86M
Important Dates
DataMeds AI upcoming earnings date is Aug 17, 2026, After Close (Confirmed).
Last Earnings DateMay 19, 2026
Next Earnings DateAug 17, 2026
Ex-Dividend Date―
Financial Position
DataMeds AI as a current ratio of 0.09, with Debt / Equity ratio of -167.26%
Current Ratio0.09
Quick Ratio0.04
Debt to Market Cap0.85
Net Debt to EBITDA-0.26
Interest Coverage Ratio-17.73
Taxes
In the past 12 months, DataMeds AI has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
DataMeds AI EV to EBITDA ratio is -0.57, with an EV/FCF ratio of -4.89.
EV to Sales2.27
EV to EBITDA-0.57
EV to Free Cash Flow-4.89
EV to Operating Cash Flow-4.89
Balance Sheet
DataMeds AI has $2.46M in cash and marketable securities with $32.62M in debt, giving a net cash position of -$30.17M billion.
Cash & Marketable Securities$2.46M
Total Debt$32.62M
Net Cash-$30.17M
Net Cash Per Share-$9.43
Tangible Book Value Per Share-$26.03
Margins
Gross margin is -125.11%, with operating margin of -347.91%, and net profit margin of -433.95%.
Gross Margin-125.11%
Operating Margin-347.91%
Pretax Margin-433.95%
Net Profit Margin-433.95%
EBITDA Margin-400.57%
EBIT Margin-414.33%
Analyst Forecast
The average price target for DataMeds AI is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-78.16%
EPS Growth Forecast-15.07%